Some people with form of skin cancer that once had grim prognosis now live long enough to die from other causes
More than half of people diagnosed with advanced melanoma now survive for at least 10 years when they receive a double hit of immunotherapy drugs, a trial has found.
The combined treatment has transformed survival rates for a form of skin cancer that once had a grim prognosis, with some patients now living long enough that they die from other causes.
Continue reading… World news | The Guardian
